Donate

May 2026 Survey

Examining the critical moments between transition and treatment, where early support matters most. This survey will take approximately 4 minutes to complete.

Veteran Voices Drive Change.

In May 2025, the Administration issued Executive Order 14401, Accelerating Medical Treatments for Serious Mental Illness, directing federal agencies to expand research into new approaches for treating PTSD, TBI, and related conditions. As policymakers consider how to move from research to real-world access, key questions remain around safety, evidence, and the role of the VA in delivering these therapies. This survey asks veterans how that pathway should be shaped. We address this EO in questions 1 through 10.

Then, questions 11-15 focus on Ibogaine specifically. Ibogaine is an experimental treatment that is not approved in the United States, yet some veterans are already traveling abroad to access it despite known medical risks. These questions explore whether and how the U.S. should approach research and potential access moving forward.

 

Veteran Voices Survey 05.26 - Views on Emerging PTSD and TBI Treatments
What is your military affiliation?
What age group do you fall into?
How willing would you be to participate in a VA-supported clinical trial for a new PTSD or TBI treatment?
Which type of clinical trial approach would you be more comfortable with?
What level of risk would you consider acceptable when participating in a clinical trial for a new treatment?
Should veterans with treatment-resistant PTSD or TBI be allowed access to promising therapies before full FDA approval, under medical supervision?
What role should the VA play in developing new treatments?
How important is it that the VA track long-term outcomes for veterans receiving new or experimental treatments?
Should new treatments be delivered under a standardized VA protocol, or allow flexibility based on individual providers and patient needs?
Where should emerging treatments for PTSD and TBI primarily take place?
If resources are limited, where should the federal government prioritize investment in new treatments?
The federal government has identified ibogaine as a compound with potential to treat serious mental illness in clinical research. Before today, were you aware of this?
Should the VA play a more active role in supporting or participating in clinical trials for treatments like ibogaine?
For veterans with treatment-resistant conditions, should access to experimental treatments like ibogaine be allowed under the Right to Try framework with appropriate medical oversight?
Ibogaine has known medical risks that require screening and monitoring. Should access be limited to controlled clinical settings even if it slows availability?
If a treatment like ibogaine successfully completes clinical trials and is approved by the FDA, should the federal government move quickly to reschedule it to allow medical use?

Left of Clinical: A New Approach to Veteran Wellness

Read the article
Impact Generations of Veterans Following in Your Footsteps

By joining our mission, you use your voice to improve the lives of veterans and their families. Your input helps guide leaders, drive change, and support those who serve now and in the future.

Join Us

Latest Articles

Fuel Veteran Voices

A small gift powers the research and advocacy that brings veterans to the decision-making table.

Donate $5+